basket trial design autoimmune diseases
Basket Trial Design for Autoimmune Diseases - 73% Overlook One Costly Problem
The costly problem that the CASTLE basket trial uncovered is the inefficiency of evaluating each autoimmune disease in isolation, which adds months to development and masks true efficacy signals. By testing CD19 CAR-T across four distinct diseases simultaneously, researchers forced a direct comparison that highlighted hidden safety and outcome gaps.